Royal DSM, a global science-based company active in health, nutrition and materials, today announces a change in the leadership of its DSM Biomedical unit. Christophe Dardel, President DSM Biomedical, will pursue his career outside DSM.
To ensure the continuing progress in Biomedical, Mr. Gerard de Reuver will assume responsibility for DSM Biomedical with immediate effect until a long-term successor is appointed.
Gerard, a Dutch national, joined DSM in 2002 after obtaining a University degree in Pharmacy & Biology and gaining senior leadership experience at amongst others Pfizer, Unilever, Perstorp, Gemini and Perkin Elmer. He held positions as President DSM Anti-Infectives and Vice President Crisis & Change. From April 2010 until August 2015, he held the position of President DSM Dyneema and played a key role in developing and strengthening the DSM Dyneema organization.
The SoundControl hearing aid is priced at $850 and comes with the typical trimmings that accompany consumer electronics, such as a connected smartphone app and a 90-day, risk-free trial.
Designed to be worn overnight, the Acuvue Abiliti orthokeratology lenses are specifically fitted to match each eye based on its unique shape.
Antoine Yver, M.D., is Centessa Pharmaceuticals’ new chief medical officer after helping AstraZeneca develop 11 medicines.